HomeCompareVTP vs JNJ

VTP vs JNJ: Dividend Comparison 2026

VTP yields 1.55% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VTP wins by $1.9K in total portfolio value
10 years
VTP
VTP
● Live price
1.55%
Share price
$76.06
Annual div
$1.18
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.9K
Annual income
$171.33
Full VTP calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VTP vs JNJ

📍 VTP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVTPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VTP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VTP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VTP
Annual income on $10K today (after 15% tax)
$131.72/yr
After 10yr DRIP, annual income (after tax)
$145.63/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $557.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VTP + JNJ for your $10,000?

VTP: 50%JNJ: 50%
100% JNJ50/50100% VTP
Portfolio after 10yr
$21.0K
Annual income
$499.56/yr
Blended yield
2.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VTP
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VTP buys
0
JNJ buys
0
No recent congressional trades found for VTP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVTPJNJ
Forward yield1.55%3.36%
Annual dividend / share$1.18$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.9K$20.0K
Annual income after 10y$171.33$827.78
Total dividends collected$1.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VTP vs JNJ ($10,000, DRIP)

YearVTP PortfolioVTP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,855$154.97$10,676$355.77+$179.00VTP
2$11,772$157.21$11,407$389.39+$365.00VTP
3$12,755$159.34$12,198$426.53+$557.00VTP
4$13,810$161.36$13,056$467.62+$754.00VTP
5$14,940$163.27$13,987$513.12+$953.00VTP
6$16,150$165.07$14,998$563.56+$1.2KVTP
7$17,448$166.77$16,098$619.52+$1.4KVTP
8$18,837$168.38$17,295$681.69+$1.5KVTP
9$20,326$169.90$18,599$750.82+$1.7KVTP
10$21,920$171.33$20,022$827.78+$1.9KVTP

VTP vs JNJ: Complete Analysis 2026

VTPStock

Seeks to track the performance of an index of the full market of inflation-protected public obligations of the U.S. Treasury.Designed for long-term investors to generate returns more closely correlated with realized inflation.Given its longer duration, the fund can be expected to have more real interest rate risk, but also higher total returns relative to a shorter-duration TIPS fund.Invests in bonds backed by the full faith and credit of the federal government and whose principal is adjusted semiannually based on inflation.Can provide protection from inflationary surprises or ”unexpected inflation.”

Full VTP Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VTP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VTP vs SCHDVTP vs JEPIVTP vs OVTP vs KOVTP vs MAINVTP vs ABBVVTP vs MRKVTP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.